These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7230874)

  • 1. Cytokinetic changes after cytosine arabinoside in acute non-lymphocyte leukemia.
    Drenthe-Schonk AM; Holdrinet RS; van Egmond J; Wessels JM; Haanen C
    Leuk Res; 1981; 5(1):89-96. PubMed ID: 7230874
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the cytotoxicity of cytosine arabinoside.
    Haanen C; Muus P; Raymakers R; Drenthe-Schonk A; Salden M; Wessels J
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):120-9. PubMed ID: 3892698
    [No Abstract]   [Full Text] [Related]  

  • 3. Prediction of response of acute nonlymphocytic leukaemia to therapy with 'high dose' cytosine arabinoside.
    Preisler HD; Epstein J; Barcos M; Priore R; Raza A; Browman GP; Vogler R; Winton E; Grunwald H; Rai K
    Br J Haematol; 1984 Sep; 58(1):19-32. PubMed ID: 6466567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of DNA synthesis by cytosine arabinoside: relation to response of acute non-lymphocytic leukemia to remission induction therapy and to stage of the disease.
    Preisler HD; Epstein J; Raza A; Azarnia N; Browman G; Booker L; Goldberg J; Gottlieb A; Brennan J; Grunwald H
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1061-8. PubMed ID: 6540689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of cytosine arabinoside on cell kinetics in adult acute leukemia and its correlation to the therapeutic response].
    Furusawa S; Adachi Y; Nomura T; Komiya M
    Rinsho Ketsueki; 1972 Dec; 13(6):943-50. PubMed ID: 4675065
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose cytosine arabinoside for treating hypocellular acute leukemia in the elderly.
    Kanamori H; Maruta A; Miyashita H; Harano H; Fukawa H; Matsuzaki M; Motomura S; Mohri H; Kodama F; Okubo T
    Am J Hematol; 1992 Jan; 39(1):52-5. PubMed ID: 1536140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Low-dose cytosine arabinoside therapy in relapsed acute leukemia: correlation of clinical response and in vitro sensitivity tests].
    Ninomiya T; Hirose M; Takaue Y; Watanabe T; Ouchi T; Sato J; Koyama T; Abe T; Suzue T
    Rinsho Ketsueki; 1987 Oct; 28(10):1763-70. PubMed ID: 3452642
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell kinetic effect of low dose arabinosyl cytosine.
    Baccarani M; Tazzari PL; Motta MR; Rizzi S; Fanin R; Fasola G; Damiani D; Dinota A; Tura S
    Br J Haematol; 1987 Sep; 67(1):33-7. PubMed ID: 3663521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose cytosine arabinoside in the treatment of resistant acute leukemia.
    Takaku F; Urabe A; Mizoguchi H; Yamada O; Wakabayashi Y; Miura Y; Sakamoto S; Yoshida M; Miwa S; Asano S
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):144-9. PubMed ID: 3859929
    [No Abstract]   [Full Text] [Related]  

  • 10. To overcome pharmacologic and cytokinetic resistance to cytarabine in the treatment of acute myelogenous leukemia by using recombinant interleukin-3?
    Brach MA; Henschler R; Mertelsmann R; Herrmann F
    Semin Hematol; 1991 Jul; 28(3 Suppl 4):39-43. PubMed ID: 1780751
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose cytosine arabinoside in the treatment of acute nonlymphoblastic leukemia and myelodysplastic syndromes.
    Hoelzer D; Ganser A; Schneider W; Heimpel H
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):208-11. PubMed ID: 4012339
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cell cycle effect of cytosine arabinoside, vincristine, and massive leukapheresis on human leukemic blasts and its application to a quadruple combination chemotherapy of acute leukemia (author's transl)].
    Yoshikawa H; Takeyama H; Nagata K; Ueda R; Ishiguro J
    Rinsho Ketsueki; 1975 Jan; 16(1):8-18. PubMed ID: 1172041
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia.
    Winter JN; Variakojis D; Gaynor ER; Larson RA; Miller KB
    Cancer; 1985 Aug; 56(3):443-9. PubMed ID: 3859362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An attempt at synchronization of marrow cells in acute leukemia: relationship to therapeutic response.
    Kremer WB; Vogler WR; Chan YK
    Cancer; 1976 Jan; 37(1):390-403. PubMed ID: 1082365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High-dose cytosine arabinoside].
    Seeber S
    Onkologie; 1985 Feb; 8(1):57-8. PubMed ID: 3885124
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of high-dose cytosine-arabinoside in the treatment of resistant acute leukemia].
    Witz F; Olive D; Lederlin P; Bordigoni P; Troussard X; Grosbois B; Schaison G; Cornu G
    Presse Med; 1987 Feb; 16(4):159-62. PubMed ID: 2950446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical basis of the treatment of leukemia with cytosine-arabinoside].
    Wilmanns H
    Schweiz Med Wochenschr; 1970 Feb; 100(7):323-5. PubMed ID: 5413922
    [No Abstract]   [Full Text] [Related]  

  • 18. [Induction of cellular differentiation in the treatment of acute leukemias: preliminary report of the use of low doses of cytosine arabinoside for the induction of remission].
    Marín-López A; Lobato-Mendizábal E; Munive-Ordóñez I; Ruiz-Argüelles GJ
    Rev Invest Clin; 1984; 36(3):247-51. PubMed ID: 6515157
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cytokinetic effect of cytosine arabinoside in clinical tests].
    Barlogie B; Büchner T; Asseburg U; Kamanabroo D
    Med Welt; 1974 Sep; 25(39):1532-4. PubMed ID: 4530133
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytosine arabinoside. Results of a cooperative study in acute childhood leukemia.
    Howard JP; Albo V; Newton WA
    Cancer; 1968 Mar; 21(3):341-5. PubMed ID: 5637945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.